Bio-Techne
TECH
#1410
Rank
HK$99.37 B
Marketcap
HK$626.41
Share price
5.03%
Change (1 day)
12.55%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Net assets

Net assets on the balance sheet as of June 2024 : HK$16.12 B

According to Bio-Techne's latest financial reports the company has HK$16.12 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bio-Techne - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$HK$15.40 B15.44%
2022-06-30$HK$13.34 B9.39%
2021-06-30$HK$12.20 B13.99%
2020-06-30$HK$10.70 B17.54%
2019-06-30$HK$9.10 B7.54%
2018-06-30$HK$8.46 B14.24%
2017-06-30$HK$7.41 B8.67%
2016-06-30$HK$6.82 B3.9%
2015-06-30$HK$6.56 B6.52%
2014-06-30$HK$6.16 B7.75%
2013-06-30$HK$5.72 B9.34%
2012-06-30$HK$5.23 B14.69%
2011-06-30$HK$4.56 B16.79%
2010-06-30$HK$3.90 B10.41%
2009-06-30$HK$3.53 B-6.86%
2008-06-30$HK$3.79 B11.04%
2007-06-30$HK$3.42 B29.4%
2006-06-30$HK$2.64 B26.98%
2005-06-30$HK$2.08 B-10.25%
2004-06-30$HK$2.31 B25.71%
2003-06-30$HK$1.84 B14.72%
2002-06-30$HK$1.60 B16.05%
2001-06-30$HK$1.38 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
HK$370.53 B 2,197.65%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$52.84 B 227.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$201.65 B 1,150.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$388.98 B 2,312.06%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$26.54 B 64.60%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$146.88 B 810.80%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.53 B-96.66%๐Ÿ‡บ๐Ÿ‡ธ USA